País: Irlanda
Idioma: inglés
Fuente: HPRA (Health Products Regulatory Authority)
CLENBUTEROL HYDROCHLORIDE
Boehringer Ingelheim Ltd
QR03CC13
CLENBUTEROL HYDROCHLORIDE
16 Micrograms/g
Granules
POM
Equine - Food
Clenbuterol
Respiratory Tract Preparations
Authorised
1988-10-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Ventipulmin Granules 16 micrograms/gram 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each gram contains ACTIVE SUBSTANCE Clenbuterol hydrochloride16 micrograms EXCIPIENTS For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Granules. White, finely grained free flowing granules. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Horses. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of respiratory disease in horses where airway obstruction due to bronchospasm and/or accumulation of mucus is a contributing factor, and improved mucociliary clearance is desirable. To be used alone or as adjuvant therapy. In particular: i) Acute, sub-acute and chronic infections where the presence of mucus and/or micro-organisms may stimulate bronchospasm or cause airway obstruction and thus an increase in airway resistance. For example, bronchitis, bronchiolitis and bronchopneumonia alone, or associated with equine influenza and other viral respiratory diseases. ii) Acute, sub-acute and chronic respiratory allergies. iii) Chronic Obstructive Pulmonary Disease (COPD) in horses. In cases accompanied by bacterial infection the adminitration of antimicrobial agents is reommended. 4.3 CONTRAINDICATIONS Do not use in cases of known hypersensitivity to the active ingredient. Do not use in horses with known cardiac disease. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 25/11/2015_ _CRN 7022431_ _page number: 1_ 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS None. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT Leer el documento completo